Katharine Bar of the Perelman School of Medicine spoke about her research on the efficacy of a new preventative treatment for people in households where someone has contracted COVID-19. “These data pave the way for REGEN-COV to be used before patients become symptomatic,” she said.
https://www.reuters.com/article/us-health-coronavirus-roche-regeneron-ph-idUSKBN2BZ0CG Reuters